Incretin-based therapies in type 2 diabetes mellitus
Clinical translation requires human CSF pharmacokinetic assays to prove BBB bypass, a rigorous dose-escalation Phase I trial to establish a safe human NOAEL for chronic dosing, and an RCT utilizing precise neurocognitive testing (e.g., MoCA) to confirm that murine transcriptomic shifts yield functional neuroprotection in humans
Your Skin, Your Way Science-backed, expert-led treatments tailored to your unique goals
Incretins are gut-derived hormones that are secreted after eating and help stimulate insulin secretion in response to glucose
Navigating this path requires a plan that prioritizes your safety and your long-term physical health
Inadequate protein intake, reduced physical activity, and dehydration may also contribute